ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 1.96% of JAGX shares are held by financial institutions. EDMOND DE ROTHSCHILD HOLDING S.A. is the top corporate investor, holding 222 shares valued at $139.00. A 0% stake in Jaguar Health, Inc. is owned by the company. NORTHERN TRUST CORP owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the JAGX insiders holding of 12.02% of the stake in company, SAGARD CAPITAL PARTNERS, L.P., 10 percent owner, holds the largest shares of 5.52M. BOCHNOWSKI JAMES J, director, is the second largest JAGX insider with ownership of 954.39K shares. SIEGEL JONATHAN B., director, stands third with possession of 12.71K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own JAGX shares is 12, representing 1.96% of the company's common stock.
EDMOND DE ROTHSCHILD HOLDING S.A., in the last quarter, reduced its stake in JAGX by -98.67% restricting it's holding to 222 shares of worth nearly $139.00. NORTHERN TRUST CORP also lessened -100% of the JAGX shares from its portfolio, reducing its holding to 0 shares of worth -. TRUIST FINANCIAL CORP also shunned JAGX shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, N/A increased its stake in JAGX by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of JAGX to its portfolio, raising its holding to - shares of worth -. N/A also increased its JAGX shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in JAGX is Sagard Capital Partners, L.P. , 10 percent owner at the company. Additionally, JAGX stock is highly held by director BOCHNOWSKI JAMES J and director Siegel Jonathan B. among others.
Company executives, directors, and other insiders own 12.02% percent of Jaguar Health, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which JAGX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BOCHNOWSKI JAMES J and NANTUCKET INVESTMENTS LTD.
There have been 0 transaction(s) during the past 6-months in which Jaguar Health, Inc. insiders have bought stock, totalling 0 shares
Around 0 Jaguar Health, Inc. shares are held by insiders, which represents about 12.02% of JAGX stock.
JAGX 10 percent owner, Sagard Capital Partners, L.P. holds the largest portfolio of the company's shares. JAGX shares owned by Sagard total nearly 5.52 million.
EDMOND DE ROTHSCHILD HOLDING S.A. is the largest institutional owner in JAGX which holds 222 shares worth $139.00 or 0% of the total JAGX shares outstanding followed by NORTHERN TRUST CORP with ownership of 0 shares representing 0% of the JAGX ownership. TRUIST FINANCIAL CORP is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the JAGX is concerned, it is a stock which is not optionable.
Number of JAGX shares short is 785.10K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 13.09M shares of JAGX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, JAGX has 9.40M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for JAGX is 1.69.